Anti-Integrin alpha V + beta 6 antibody [avB6 53a.2]
5
(2 Reviews)
|
(6 Publications)
Anti-Integrin alpha V + beta 6 antibody [avB6 53a.2] (ab97588) is a rat monoclonal antibody detecting Integrin alpha V + beta 6 in Flow Cytometry, ICC/IF, Neut. Suitable for Human.
- Trusted since 2010
View Alternative Names
CD51, MSK8, VNRA, VTNR, ITGAV, Integrin alpha-V, Vitronectin receptor, Vitronectin receptor subunit alpha
Reactivity data
Product details
Anti-Integrin alpha V + beta 6 antibody [avB6 53a.2] (ab97588) is a rat monoclonal antibody and is validated for use in Flow Cytometry (Flow Cyt), Immunocytochemistry/immunofluorescence (ICC/IF), Neutralising in Human samples.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Integrin αvΒ6 engages in binding with specific ligands such as fibronectin vitronectin and latency-associated peptides. This protein forms a part of a larger integrin family existing as a heterodimer playing an important role in the activation of transforming growth factor-beta (TGF-Β). The interaction between integrin αvΒ6 and its ligands contributes to cell proliferation migration differentiation and modulation of the local cellular environment affecting tissue remodeling and immunity.
Pathways
Integrin αvΒ6 is involved in TGF-Β signaling and the epithelial-mesenchymal transition (EMT) pathway. These pathways are fundamental for regulating developmental processes and tissue repair providing cues for cell fate and homeostasis. Additionally integrin αvΒ6 associates with other proteins including fibronectin and vitronectin enhancing its role in mediating cell-extracellular matrix interactions which supports cellular communication and migration essential for these pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 11:8315 PubMed33859325
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncogene 39:2624-2637 PubMed32005976
2020
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 14:3880-3886 PubMed29042996
2017
Applications
Unspecified application
Species
Unspecified reactive species
Human gene therapy 23:960-79 PubMed22708837
2012
Applications
Flow Cyt
Species
Human
Cancer research 68:3295-303 PubMed18451156
2008
Applications
Unspecified application
Species
Unspecified reactive species
Immunology 107:77-85 PubMed12225365
2002
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com